The Silicon Review
Company | Management | Description |
Biovista www.biovista.com |
Dr. Andreas Persidis, Co-founder & CEO |
Biovista delivers custom drug repositioning, drug de-risking and clinical hold solutions for the Biopharma Industry. Biovista also develops powerful platform technologies for Life science and Biotechnology companies. Biovista has an ongoing R&D program to develop new and improve existing products and services. |
Foundation Medicine www.foundationmedicine.com |
Brian Alexander, MD, MPH, CEO |
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. |
Throne Biotechnologies thronebio.com |
Dr. Yong Zhao, CEO & President |
Throne Biotechnologies (Throne) is a clinical-stage therapeutic company with a disruptive stem cell technology that can fundamentally reverse type 1 diabetes (T1D), alopecia areata (AA) and other autoimmune diseases through immune education of Stem Cell Educator therapy (“Educator Therapy”) at the root causes. |
Cyclica www.cyclicarx.com |
Naheed Kurji, Co-founder, President & CEO |
Cyclica decentralizes innovation with technology, build novel data-driven pipelines, and fuel cross-organizational collaborations at a molecular level. |
Orna Therapeutics www.ornatx.com |
Thomas Barnes, PhD, CEO |
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. |